Two Sigma Investments, LP Ultragenyx Pharmaceutical Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 614,948 shares of RARE stock, worth $26.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

614,948

Previous 755,683 18.62%

Holding current value

$26.2 Million

Previous $42 Million 38.37%

% of portfolio

0.06%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$42.07 - $57.72 $5.92 Million - $8.12 Million	-140,735 Reduced 18.62%	614,948 $25.9 Million
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $7.53 Million - $11.1 Million	187,374 Added 32.97%	755,683 $42 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $5.73 Million - $7.9 Million	152,995 Added 36.84%	568,309 $23.4 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $12.4 Million - $15.5 Million	288,704 Added 228.03%	415,314 $19.4 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $2.77 Million - $4.3 Million	87,410 Added 222.98%	126,610 $6.05 Million
Q3 2023 Nov 14, 2023	SELL	$34.92 - $46.66 $12.7 Million - $17 Million	-364,574 Reduced 90.29%	39,200 $1.4 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $3.16 Million - $4.41 Million	-84,582 Reduced 17.32%	403,774 $18.6 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $1.72 Million - $2.26 Million	46,420 Added 10.5%	488,356 $19.6 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $6.29 Million - $8.64 Million	186,547 Added 73.04%	441,936 $20.5 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $7.95 Million - $13.2 Million	198,889 Added 352.02%	255,389 $10.6 Million
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $806,080 - $1.5 Million	17,600 Added 45.24%	56,500 $3.37 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $2.42 Million - $3.28 Million	38,900 New	38,900 $2.83 Million
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $1.91 Million - $2.28 Million	-25,900 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $20.6 Million - $27.1 Million	-264,364 Reduced 91.08%	25,900 $2.34 Million
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $13.5 Million - $16.9 Million	145,944 Added 101.13%	290,264 $27.7 Million
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $8.98 Million - $14.1 Million	84,008 Added 139.29%	144,320 $16.4 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $4.61 Million - $9.68 Million	54,595 Added 954.96%	60,312 $8.35 Million
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $2.47 Million - $3.05 Million	-33,837 Reduced 85.55%	5,717 $470,000
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $1.86 Million - $3.09 Million	39,554 New	39,554 $3.09 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $279,944 - $355,594	-7,759 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $329,757 - $489,670	7,759 New	7,759 $332,000

Others Institutions Holding RARE

# of Institutions

344

Shares Held

86.6M

Call Options Held

675K

Put Options Held

846K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.98B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Ultragenyx Pharmaceutical Inc. Transaction History